Patients with aggressive forms of cancer are faced with limited treatment options further confined by geography or limited to standard care.
We work as a partner for patients, physicians, and other nonprofit foundations to provide general education about their diagnosis, treatment options, and access to therapeutics whenever possible.
We direct patients and families toward clinically focused, actionable projects. It’s our goal to fund work beyond academic understanding toward the goal of furthering treatment options.
We hope to help patients with the cost of treatment by finding alternate forms of access, cost-saving measures, or financial support when possible for patients with demonstrated financial need.
We leverage years of international collaboration and experience guiding patients with advanced forms of cancer. Well-informed, individual combinations have the potential to optimize treatment, improve survival, and delay progression.
Interrogating tumor biology through genetic sequencing and identifying targets for an optimized treatment strategy.
Support for customized solutions recommended by a board of oncologists, pharmacologists, cancer biologists, geneticists, surgeons, radiologists, pathologists, and bioinformatics experts.
Presenting recommended treatments to the patient and/or their healthcare team. The treating provider always makes the final decision about implementing treatment.
monitoring guides and informs treatment recommendations from the tumor board, healthcare team and providers. Feedback allows optimization and directs additional therapy.
we educate interested patients from a data-driven standpoint and help with compassionate access/insurance when possible.